| AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons G Amadoro, V Corsetti, F Florenzano, A Atlante, MT Ciotti, MP Mongiardi, ... Neurobiology of disease 62, 489-507, 2014 | 77 | 2014 |
| Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma G Fianco, MP Mongiardi, A Levi, T De Luca, M Desideri, D Trisciuoglio, ... Elife 6, e22593, 2017 | 65 | 2017 |
| Frataxin participates to the hypoxia-induced response in tumors I Guccini, D Serio, I Condo, A Rufini, B Tomassini, A Mangiola, G Maira, ... Cell death & disease 2 (2), e123-e123, 2011 | 60 | 2011 |
| Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells MP Mongiardi, M Savino, L Bartoli, S Beji, S Nanni, F Scagnoli, ... Scientific reports 5 (1), 15494, 2015 | 47 | 2015 |
| Cancer response to therapy-induced senescence: A matter of dose and timing MP Mongiardi, M Pellegrini, R Pallini, A Levi, ML Falchetti Cancers 13 (3), 484, 2021 | 41 | 2021 |
| Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts ML Falchetti, MP Mongiardi, P Fiorenzo, G Petrucci, F Pierconti, ... International journal of cancer 122 (6), 1236-1242, 2008 | 39 | 2008 |
| Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation MP Mongiardi, G Radice, M Piras, V Stagni, S Pacioni, A Re, S Putti, ... Oncogene 38 (27), 5413-5424, 2019 | 38 | 2019 |
| Angiogenesis and hypoxia in glioblastoma: a focus on cancer stem cells M Patrizia Mongiardi CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2012 | 32 | 2012 |
| c-MYC inhibition impairs hypoxia response in glioblastoma multiforme MP Mongiardi, M Savino, ML Falchetti, B Illi, F Bozzo, C Valle, ... Oncotarget 7 (22), 33257, 2016 | 31 | 2016 |
| Telomerase inhibition impairs tumor growth in glioblastoma xenografts ML Falchetti, P Fiorenzo, MP Mongiardi, G Petrucci, N Montano, G Maira, ... Neurological research 28 (5), 532-537, 2006 | 31 | 2006 |
| HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo P Fiorenzo, MP Mongiardi, D Dimitri, M Cozzolino, A Ferri, N Montano, ... International journal of oncology 36 (4), 785-791, 2010 | 29 | 2010 |
| Transport of cationic liposomes in a human blood brain barrier model: Role of the stereochemistry of the gemini amphiphile on liposome biological features B Simonis, D Vignone, OG Paz, E Donati, ML Falchetti, C Bombelli, ... Journal of Colloid and Interface Science 627, 283-298, 2022 | 23 | 2022 |
| Oxygen sensing is impaired in ATM-defective cells MP Mongiardi, V Stagni, M Natoli, D Giaccari, I D’Agnano, ML Falchetti, ... Cell Cycle 10 (24), 4311-4320, 2011 | 21 | 2011 |
| Neuropeptide TLQP-21, a VGF internal fragment, modulates hormonal gene expression and secretion in GH3 cell line P Petrocchi Passeri, L Biondini, MP Mongiardi, N Mordini, S Quaresima, ... Neuroendocrinology 97 (3), 212-224, 2013 | 15 | 2013 |
| Glioblastoma cells do not affect axitinib-dependent senescence of HUVECs in a transwell coculture model M Merolle, MP Mongiardi, M Piras, A Levi, ML Falchetti International Journal of Molecular Sciences 21 (4), 1490, 2020 | 8 | 2020 |
| Gene expression profiling of hypoxic response in different models of senescent endothelial cells MP Mongiardi, M Merolle, V Fustaino, A Levi, ML Falchetti Aging Clinical and Experimental Research 33, 1993-2001, 2021 | 7 | 2021 |
| Characterization of glioblastoma cells response to regorafenib MP Mongiardi, M Buccarelli, A Formato, E Orecchini, M Salbini, V Ricci, ... Cancers 14 (24), 6193, 2022 | 3 | 2022 |
| AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons. Neuobiol Dis 2014; 62: 489-507 G Amadoro, V Corsetti, F Florenzano, A Atlante, MT Ciotti, MP Mongiardi, ... | 3 | |
| Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness MP Mongiardi, R Pallini, QG D'Alessandris, A Levi, ML Falchetti Expert Reviews in Molecular Medicine 26, e5, 2024 | 1 | 2024 |
| Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing. Cancers 2021, 13, 484 MP Mongiardi, M Pellegrini, R Pallini, A Levi, ML Falchetti s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
Andrea Levidirettore ricerca IBCN CNRVerified email at cnr.it
